Oncolytics Biotech (R) Announces Study to Investigate Combination of Pelareorep and Avelumab in Metastatic Breast Cancer in Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer
Stock Information for Oncolytics Biotech Inc.
Loading
Please wait while we load your information from QuoteMedia.